Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  MUMBAI STOCK EXCHANGE  >  Dr. Reddy's Laboratories Limited    500124   INE089A01023

DR. REDDY'S LABORATORIES LIMITED

(500124)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Dr Reddy Laboratories : Data breach prompts India's Dr Reddy's to shut key plants - ET Now

10/22/2020 | 01:55am EST

BENGALURU, Oct 22 (Reuters) - A data breach at Dr Reddy's Laboratories Ltd prompted the Indian drugmaker to shut its key plants globally, television channel ET Now reported on Thursday, citing sources.

Shares of the company, which has a partnership to run clinical trials of Russia's Sputnik-V COVID-19 vaccine in India, fell as much as 4.3% on the news, dragging the Nifty pharma sub-index down 2%.

The data breach occurred at servers of the company and plants in the United States, United Kingdom, Brazil, India and Russia were impacted, the ET Now report said.

Dr Reddy's did not immediately respond to Reuters' queries.

The Russian Direct Investment Fund (RDIF) and Dr Reddy's got renewed approval to conduct late-stage clinical trials in India for the Sputnik-V vaccine after the country's regulator had earlier asked them to conduct a smaller trial.

(Reporting by Nallur Sethuraman in Bengaluru; Editing by Sriraj Kalluvila)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
DR. REDDY'S LABORATORIES LIMITED 1.92% 4898.8 End-of-day quote.70.27%
EURO / BRAZILIAN REAL (EUR/BRL) 0.85% 6.4133 Delayed Quote.42.02%
All news about DR. REDDY'S LABORATORIES LIMITED
04:21aDR REDDY LABORATORIES : . Reddy's to acquire select Anti-Allergy brands from Gle..
PU
11/28DR REDDY LABORATORIES : . Reddy's to Acquire Select Anti-Allergy Brands from Gle..
BU
11/27Pharma firm in India to make Russia's Sputnik V COVID-19 vaccine
RE
11/20DR REDDY LABORATORIES : Half yearly disclosure of related party transactions - S..
PU
11/17India pins hopes on locally-tested COVID-19 vaccines given Pfizer constraints
RE
11/16APPILI THERAPEUTICS : Reports Financial and Operational Results for Second Quart..
AQ
11/12DR REDDY LABORATORIES : Announces the Launch of Succinylcholine Chloride Injecti..
BU
11/12India's Serum says made 40 million doses of AstraZeneca's COVID vaccine, to m..
RE
11/09DR REDDY LABORATORIES : Presents Preclinical Data at SITC 2020 Demonstrating Sig..
BU
10/29DR REDDY LABORATORIES : Outcome of Board Meeting
PU
More news
Financials
Sales 2021 193 B 2 607 M 2 607 M
Net income 2021 27 597 M 373 M 373 M
Net cash 2021 10 068 M 136 M 136 M
P/E ratio 2021 29,2x
Yield 2021 0,53%
Capitalization 801 B 10 822 M 10 831 M
EV / Sales 2021 4,10x
EV / Sales 2022 3,57x
Nbr of Employees 21 650
Free-Float 68,2%
Chart DR. REDDY'S LABORATORIES LIMITED
Duration : Period :
Dr. Reddy's Laboratories Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DR. REDDY'S LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 33
Average target price 5 522,33 INR
Last Close Price 4 829,60 INR
Spread / Highest target 32,5%
Spread / Average Target 14,3%
Spread / Lowest Target -17,2%
EPS Revisions
Managers
NameTitle
Erez Israeli Chief Executive & Operating Officer
Saumen Chakraborty President, CFO & Global Head-IT
Satish Kallam Reddy Co-Chairman
Gunupati Venkateswara Prasad Co-Chairman & Managing Director
Kalpana Jaisingh Morparia Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
DR. REDDY'S LABORATORIES LIMITED70.27%10 822
JOHNSON & JOHNSON-1.28%379 086
ROCHE HOLDING AG-3.66%285 972
PFIZER INC.0.30%206 939
NOVARTIS AG-11.80%203 829
MERCK & CO., INC.-12.19%202 049